Etypharm is a French private company, also operating in FR. The firm provides healthcare services.

Warner-Lambert Co. used to manufacture and market pharmaceuticals, consumer health care products & confectionery. Its pharmaceutical products were ethical pharmaceuticals, biological products and hard-gelatin capsules. Its consumer health products were a wide range of products like oral care mouthwash/dental rinses, toothpaste, effervescent denture cleaning tablets, upper respiratory cold & sinus preparations, antihistamines, allergy products and cough syrups/suppressants. The company was headquartered in Morris Plains, NJ.

Roussel UCLAF.

At Dynagen, we create software solutions that exceed the requirements of our clients and will revolutionise how your business functions. We launched in 2006, (Trading under the name Horizon Tech) and already have successfully partnered with companies to get them solid results for a fair price. Our process starts with a consultation to discover the exacts needs of your organisations. We then tailor our solutions to create software that will exceed your expectations in both performance and return on investment. Great software starts with a great chat. While we admit we are not short on “geekiness” we see communication as our greatest asset. It’s through talking with you that we will understand exactly what you need and then and only then will be be able to deliver a great software project. That’s why our clients are some of the most satisfied that you’ll ever meet and why they return to us time and time again to help them with their software requirements. Dynagen have a long relationship with Microsoft Window but also have recently been developing more and more for iOS. The demand for both iPhone and Android business apps means that we forsee continued growth in this area. To discover more about our capabilities and how we can help your business or organisation click here to get in touch. We work hard to represent our business on the web but sometimes a chat on the phone is the quickest way to find out if we are a good match for each other. We must warn you beforehand we are a very busy company and you may need to join a waiting list to become a Dynagen customer. The demand for our services is such that as much as you are interviewing us, we interview our clients to find out of they are the type of business we can work work.

ALK is a global research-driven pharmaceutical company that focuses on prevention, diagnosis and treatment of allergies. Since 1923 ALK has been working to improve the quality of life for allergy patients by developing drugs that target the cause of allergy. ALK is the world leader in allergy immunotherapy - a unique treatment of the cause of allergies. The treatment induces a protective immune response that provides a sustained reduction of allergy symptoms and reduces the risk of developing asthma. ALK provides allergy immunotherapy products as injections, sublingual drops and sublingual tablets, which is the newest, best documented and most convenient treatment for patients. The portfolio of products also includes an adrenaline used to treat severe allergic reactions (anaphylactic shock). ALK invests annually approx. 20% of revenue in research that aims to develop new, evidence-based allergy immunotherapy. Research and development pipeline includes sublingual allergy immunoterapy tablets against ragweed, house dust mite and tree pollen allergy. ALK has signed partnership agreements with Merck and Torii Pharmaceutical, concerning the development, registration and commercialisation of tablets in Northern America and Japan. ALK has approx. 1,800 employees with subsidiaries, production facilities and distributors worldwide. The company headquarters is in Denmark and is listed on NASDAQ OMX Copenhagen (OMX: ALK B). In 2013 the turnover was more than DKK 2.2 billion (EURm 300).

Laboratorios Bagó was born in Argentina and grew with the century. Since its foundation, in 1934, it assumed a commitment that accompanies us until today: build a cutting-edge pharmaceutical company and excellence in the service of health. Products in more than 50 countries, 11 production plants in the world, 85 patents obtained in 15 countries by own research and development and more than 480 products covering 46 therapeutic lines are some of the achievements that distinguish our trajectory.

Beijing Qi Yuan Yi De Pharmaceuticals Research Centre is a private company headquartered in Beijing, China, involved in pharmaceutical preparations.

Yantai Yinuoyi Biomedical Technology Co., Ltd., established on 2013-09-12, Business scope includes pharmaceutical products,Research on medical diagnostic reagents,Technology transfer and related technical consulting services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Biohit Oyj engages in the development, manufacture, and market of diagnostic tests and analysis systems. It also offers acetaldehyde binding products, monoclonal antibodies, and instruments. The company was founded by Osmo Suovaniemi in 1988 and is headquartered in Helsinki, Finland.

Part of Lunan Pharmaceutical Group Co., Ltd., Shandong New Time Pharmaceutical Co. Ltd. is a Chinese company located in Linyi that manufactures pharmaceutical products.

Servier are driven by the belief in the excellence of their profession. Theirs is a research-based organization, fulfilling a basic need and dedicated to the future.

Hainan Simcere Pharmaceutical Co., Ltd. is a generic phamaceutical manufacturing company. It offers products involving treatments for cancer, cerebrovascular diseases, infections, rheumatoid arthritis, nausea & vomiting associated with chemotherapy. The company was founded in April 1993 and is headquartered in Hainan, CN.

Nanjing Ningdan New Drug Technology Co., Ltd., established on 2020-12-28, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development;Natural science research and experimental development(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Teikoku Seiyaku Co. Ltd. manufactures and distributes pharmaceuticals. It offers poultices, including Lidoderm, medicated patches and plasters, and anti-inflammatory plasters. The company also provides prescription drugs, such as Dovonex ointment, Hap Star ID, Glycerin Enema, Steronema, Bari-Enema, Magtect U, and Zikilion syrups. Teikoku Seiyaku was founded in 1848 and is headquartered in Higashi Kagawa, Japan

Liomont is a pharmaceutical company that researches, develops and manufactures medicines for medication, prescription and OTC markets.

Sclavo Spa is an Italian private company located in Siena that operates as a laboratory.

Fujisawa Pharmaceutical Co. Ltd. develops, manufactures and markets pharmaceuticals and medical products. The Group's principal activity is the manufacture and sale of pharmaceuticals, medical equipment and supplies, home care products, chemicals and animal health products. Pharmaceuticals (ethical drugs, OTC drugs, toilet goods) accounted for 91% of fiscal 2002 revenues and other operations (food additives, industrial chemicals, animal drugs, research and clinical reagents). It was founded in 1894 and was headquartered in Osaka, JP

McNeil AB operates within the consumer health care division that develops and manufactures medicines. It specializes in the manufacture of self-care medicines. The firm offers NICORETTE products for the global market. The company was founded in December 2006 and is headquartered in Helsinborg, Sweden.

Orexo is a pharmaceutical company based in Uppsala, Sweden initially financed with venture capital provided by HealthCap. The company was founded in 1995 and their first product Diabact UBT, a breath test for diagnosing the causative agent of stomach ulcers (Helicobacter pylori), was introduced in 2000. In 2003, the company adopted the name Orexo and in 2005 the company was listed on the Stockholm Stock Exchange.On March 29, 2019 a U.S. jury rejected a claim by Sweden’s Orexo AB that two generic opioid-addiction treatments created by Teva Pharmaceutical Industries Ltd. infringed a patent for Orexo’s biggest drug, Zubsolv.